Literature DB >> 10563586

Comparison of the structures of beta amyloid peptide (25-35) and substance P in trifluoroethanol/water solution.

S Lee1, Y H Suh, S Kim, Y Kim.   

Abstract

The three-dimensional structure of beta amyloid peptide (25-35) in aqueous solution with 50% (vol/vol) 2,2,2-trifluoroethanol was determined by NMR spectroscopy. Beta amyloid peptide(Abeta) is the major component of senile plaques found in the brain of patient of Alzheimer's disease. Abeta25-35 is biologically active fragment of Abeta and exhibits some sequence homology with the tachykinin family. In this study, we present the structural similarity between Abeta25-35 and substance P which is a member of tachykinin family in order to examine the possibility of sharing pathways mediated by tachykinin receptors. Both peptides have alpha-helical structures in their C-terminal regions and aromatic rings or hydrophobic side chains in the center of the helix protrude outside. These conformational features are expected to be the key for the interaction with the receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10563586     DOI: 10.1080/07391102.1999.10508369

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  5 in total

1.  Beta-amyloid toxicity in embryonic rat astrocytes.

Authors:  Poincyane Assis-Nascimento; Karen M Jarvis; Jeremy R Montague; Laura M Mudd
Journal:  Neurochem Res       Date:  2007-04-04       Impact factor: 3.996

2.  Environmental polarity induces conformational transitions in a helical peptide sequence from bacteriophage T4 lysozyme and its tandem duplicate: a molecular dynamics simulation study.

Authors:  Harpreet Kaur; Yellamraju U Sasidhar
Journal:  J Mol Model       Date:  2015-03-17       Impact factor: 1.810

3.  Beta-amyloid toxicity and reversal in embryonic rat septal neurons.

Authors:  Karen Jarvis; Poincyane Assis-Nascimento; Laura M Mudd; Jeremy R Montague
Journal:  Neurosci Lett       Date:  2007-08-09       Impact factor: 3.046

4.  Modulating charge-dependent and folding-mediated antimicrobial interactions at peptide-lipid interfaces.

Authors:  Patrizia Iavicoli; François Rossi; Baptiste Lamarre; Angelo Bella; Maxim G Ryadnov; Luigi Calzolai
Journal:  Eur Biophys J       Date:  2016-11-10       Impact factor: 1.733

Review 5.  Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer's Disease.

Authors:  José J Jarero-Basulto; Martha C Rivera-Cervantes; Deisy Gasca-Martínez; Francisco García-Sierra; Yadira Gasca-Martínez; Carlos Beas-Zárate
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.